Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

16

Revenue 2017

Shire

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Shire's 2013 CNS, immunology and metabolic's sales performance.

Shire

Immunology keeps Shire figures solid as Takeda takeover nears

Immunology keeps Shire figures solid as Takeda takeover nears acquisition target Shire – and on the whole the UK-listed firm didn’t disappoint. ... However, Shire’s drugs for haemophilia patients with inhibitors such as Feiba came under competitive pressure from the likes of Roche’s recently-approved

NHS England says yes to Roche's Hemlibra

NHS England says yes to Roche's Hemlibra Among the treatments and interventions listed in the latest review at 'Level 2' were Shire’s Obizur (susoctocog alfa) for patients with acquired haemophilia A (a rare form of the disease)

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug therapies.”. Prior to Celgene, Dr. Beck was senior vice president of pharmaceutical development at Shire from 2012 to 2016.

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump Takeda to sell Osaka HQ to help cover Shire costs. Takeda’s $63bn purchase of Shire is the biggest pharma merger for some years, and the Japanese pharma company is making

Malthus’ orphans

Malthus’ orphans Shire. The attractiveness of rare diseases, orphan drugs and other ‘ultra niche’ strategies is their high relative profitability; governments tolerate high cost per patient because the patients are few and often

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics